Xlumena
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | $3.0m | Series A | |
$7.0m | Series B | ||
N/A | $5.9m | Debt | |
N/A | $6.0m | Debt | |
$25.0m | Series C | ||
$75.0m Valuation: $75.0m | Acquisition | ||
Total Funding | $35.0m |
Recent News about Xlumena
EditXLumena specializes in developing innovative medical devices, particularly for gastroenterology, aimed at improving patient outcomes and safety. The company operates in the healthcare sector, focusing on creating single-use medical instruments that reduce the risk of cross-contamination and infection. XLumena's primary clients include hospitals, clinics, and healthcare providers who require advanced, reliable, and safe medical tools. The business model revolves around the research, development, and sale of these specialized devices, generating revenue through direct sales and partnerships with healthcare institutions. By prioritizing patient-focused innovation, XLumena aims to set new standards in medical technology and patient care.
Keywords: medical devices, gastroenterology, single-use, patient safety, innovation, healthcare, infection control, hospitals, clinics, advanced technology.